Elucid FFR-IQ (B.1)— 510(k) K262015

Substantially Equivalent

Elucid Bioimaging, Inc.

FDA 510(k) clearance K262015 for Elucid FFR-IQ (B.1), Substantially Equivalent on 2026-09-29. Applicant: Elucid Bioimaging, Inc.. Device class: 2.

Summary

Elucid FFR-IQ (version B.1) is coronary physiology software filed under PJA, coronary vascular physiologic simulation software. That code covers software meant to aid in identifying functionally significant cardiovascular disease. The record doesn't describe the inputs or outputs for this version.

Class II, 21 CFR 870.1415, Cardiovascular panel, Traditional 510(k).

Elucid Bioimaging, Inc. filed from Boston, Massachusetts. Review took 106 days (June 15 to September 29, 2026).

Clearance details

Applicant
Elucid Bioimaging, Inc.
Product code
Product code PJA
Device class
Class 2
Regulation
21 CFR 870.1415
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Boston, MA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code PJA

view all

More clearances from Elucid Bioimaging, Inc.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.